DNTH icon

Dianthus Therapeutics
DNTH

Overview Fund Activity

30 hedge funds and large institutions have $136M invested in Dianthus Therapeutics in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 0 increasing their positions, 21 reducing their positions, and 23 closing their positions.

Holders
30
Holders Change
-14
Holders Change %
-31.82%
% of All Funds
0.48%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
9
Increased
–
Reduced
21
Closed
23
Calls
$4K
Puts
–
Net Calls
+$4K
Net Calls Change
-$7K

Top Buyers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$29M
2
FFM
2
Fairmount Funds Management
Pennsylvania
$26.4M
3
5VM
3
5AM Venture Management
California
$20.1M
4
APM
4
Avidity Partners Management
Texas
$16.6M
5
VA
5
VR Adviser
New York
$12.7M

Top Sellers

1
Citadel Advisors
1
Citadel Advisors
Florida
$1.44M
2
Verition Fund Management
2
Verition Fund Management
Connecticut
$0
3
HMC
3
Harvard Management Company
Massachusetts
$0
4
Two Sigma Advisers
4
Two Sigma Advisers
New York
$0
5
HCA
5
Harbor Capital Advisors
Illinois
$0
Name Market Value Shares Shares
Change 		Shares
Change %
AF
51
Allworth Financial
California
– – -23 Closed
Barclays
52
Barclays
United Kingdom
– – -3 Closed
Simplex Trading
53
Simplex Trading
Illinois
– – -1 Closed
CFGS
54
Concourse Financial Group Securities
Alabama
– – – –
1 2
3